CD44 and cancer: Studies have shown that as low as 100 CD44+/CD24−/low cancer cells of the brain, breast, pancreas, lung, and colon can initiate tumors, while greater than 10,000 cells of other non-CSC counterparts were unable to [54,55,56,57].